THOMAS BEHAR: Open Payments
NPI 1437732633 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 15 payments from 8 companies in 2025. Trend: 2023 $2,862 · 2024 $4,708 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $152 |
| Janssen Biotech, Inc. | 2 | $52 |
| UCB, Inc. | 1 | $35 |
| Organon LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: SKYRIZI, TREMFYA, Bimzelx, RINVOQ, VTAMA, COSENTYX, DUPIXENT, Zoryve.
Industry payments across NY — which companies pay providers there.
